Founder and Chief Scientific Officer

Dr. Bhargava received Ph.D. from Indian Institute of Science, Bangalore, India. After post-doctoral studies with Professor Sherman Weissman at Yale University, Dr. Bhargava joined Bayer Corporation. At Bayer, he worked on target identification, target validation and assay development projects in osteoarthritis, osteoporosis and oncology therapeutic areas. Within oncology, he worked on various drug discovery projects including kinases, cytotoxics and hypoxia pathway inhibitors. Dr. Bhargava led cross functional, preclinical drug discovery project teams towards Phase I clinical trials. Dr. Bhargava has authored several peer-reviewed international scientific publications.

Senior Scientist

Dr. Saluja is an interdisciplinary scientist with 15 years of wet lab experience. She has extensive molecular biology, synthetic biology, and genetics experience in bacteria, yeast, mammalian cells, and mice. She has worked with Dr. Frank Ruddle (Yale University) and Dr. Jim Haber (Brandeis University). She received her PhD from Harvard University with Dr. Chih-Hao Lee, studying host-pathogen interactions in the context of metabolic diseases. After graduating, she worked with Dr. Jim Collins at MIT, studying antibiotic effects on host metabolism. In addition to her scientific work, Dr. Saluja has extensive experience writing and editing manuscripts for top tier journals and grants for private and public funding agencies. 

Lab Manager and Data Analyst

Mr. Taranto is responsible for administration, logistics, inventory management, and data analysis. His career has included positions in several industries, including insurance, technology, and construction, which has allowed him to develop a diverse skillset. Daniel plans to continue to support business development and vendor relationships while learning and developing his skills as a scientist.

QA Consultant

Dr. Menacherry provides QA/QC consultancy to Shakti Bioresearch. He has years of experience leading QA/QC programs at a variety of CROs with GLP capabilities.